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ABSTRACT
A complex of the three (aeh) core subunits and the b2
sliding clamp is responsible for DNA synthesis by
Pol III, the Escherichia coli chromosomal DNA rep-
licase. The 1.7 Å crystal structure of a complex
between the PHP domain of a (polymerase) and
the C-terminal segment of e (proofreading exonucle-
ase) subunits shows that e is attached to a at a site
far from the polymerase active site. Both a and e
contain clamp-binding motifs (CBMs) that interact
simultaneously with b2 in the polymerization mode
of DNA replication by Pol III. Strengthening of both
CBMs enables isolation of stable aeh:b2 complexes.
Nuclear magnetic resonance experiments with
reconstituted aeh:b2 demonstrate retention of high
mobility of a segment of 22 residues in the linker
that connects the exonuclease domain of e with its
a-binding segment. In spite of this, small-angle
X-ray scattering data show that the isolated
complex with strengthened CBMs has a compact,
but still flexible, structure. Photo-crosslinking with
p-benzoyl-L-phenylalanine incorporated at different
sites in the a-PHP domain confirm the conform-
ational variability of the tether. Structural models
of the aeh:b2 replicase complex with primer-
template DNA combine all available structural data.
INTRODUCTION
The replicative DNA polymerases that synthesize the bulk of
chromosomal DNA invariably contain two active sites.
Primer DNA is extended processively by incorporation of
nucleotides at the polymerase site, while mismatched nucleo-
tides that are incorporated infrequently are removed at the
30–50 (proofreading) exonuclease site. In all proofreading
polymerases, the two sites are spatially separated, so a mech-
anism is required to transfer the primer-template DNA from
one site to the other when the polymerase needs to transit
between the polymerization and proofreading modes (1).
The 17-subunit DNA polymerase III holoenzyme (Pol
III HE) is the chromosomal replicase in Escherichia coli,
and is composed of 10 different proteins (1). The three-
subunit catalytic core contains one each of the  (1160
residues; 130 kDa), e (243 residues; 27 kDa) and 
(8.8 kDa) subunits encoded by the dnaE, dnaQ and holE
genes, respectively. The  subunit contains the polymerase
active site (2,3), the e subunit is responsible for the 30–50
proofreading exonuclease activity (4) and the  subunit
has no identified enzymatic activity (5). The e core
complex is active alone as a proofreading DNA polymer-
ase, and co-purification of these three subunits demon-
strates their tight physical association (6,7). Direct
interactions between e and  (8) and e and  (5) have
been demonstrated, but no interaction has been detected
between  and .
The e core complex of E. coliDNA Pol III has proven
unsuitable for X-ray crystallography, probably because
crystallization is impeded by the highly flexible polypep-
tide linker connecting the globular N-terminal domain of e
with its C-terminal peptide that binds to  (9). The
complex is also not amenable to detailed NMR studies
because of its high molecular mass. However, 3D struc-
tures of subdomains of the complex have been determined
by X-ray crystallography and in solution by NMR
spectroscopy.
Two crystal structures of  have been reported: of a
C-terminally truncated version (917) of E. coli  (10)
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and of full-length Thermus aquaticus (Taq)  (11). Crystal
structures are also available of the N-terminal globular
domain of E. coli e (e186; Figure 1A), both alone (12)
and in complex with HOT, the phage P1 homolog of 
(13,14). In addition, the structure of the e186: complex
was determined by NMR spectroscopy (15,16). Full-
length e includes an additional C-terminal segment of 57
residues, in the following referred to as eCTS (Figure 1A).
Residues near the C terminus of the eCTS are known to be
responsible for binding of  (9,17,18). The binding site of e
has been shown to be within the first 320 residues of 
(19), which includes the N-terminal 270-residue PHP
domain (20) (Figure 1C and D). Residues 190–212 of
the eCTS had earlier been predicted to comprise an
interdomain ‘Q-linker’ sequence (21). Solution NMR
showed that residues in the eCTS are flexible and that
those around the Q-linker (residues between Thr183 and
Thr201, at least) remain so even in the context of the
165 kDa e core complex. Moreover, the e186 domain
does not interact, even weakly, with  (9).
The homodimeric 2 sliding clamp is responsible for
processivity of DNA synthesis by the bacterial replisome.
The 2 dimer forms a donut-shaped structure (22) that
encircles (23) and slides on double-stranded (ds) DNA.
Each protomer of 2 has a binding site for penta- or
hexa-peptide clamp-binding motifs (CBMs) that are
found in many proteins, including the  subunit of the
seven-subunit Pol III clamp loader and all five E. coli
DNA polymerases (I–V) (24), among others (25). The
interaction of CBMs with the 2 sliding clamp provides
a specific way of recruiting requisite enzymes to 30 ends of
primer-template DNAs, and the Pol III  subunit has two
CBMs: one is at the C-terminus and may be involved in
polymerase recycling during lagging-strand replication;
the other is an internal site that ensures processivity of
the replicase (25,26).
In the present work, we identified the exact site and
mode of binding of e on  by determining the crystal
structures of constructs where residues 209–243 and
200–243 of eCTS were fused to the N-terminus of the
PHP domain of  (residues 1–270, referred to as 270)
via a nine-residue linker that had been shown in another
context to be flexible (27,28). A fortuitous PCR-generated
mutation in 270, Leu21Pro, enabled crystallization. As
the binding site of e on  turned out to be far from the
active site of the polymerase, we further investigated the
tether between the N-terminal proofreading domain of e
and the C-terminal -binding peptide. Building a model of
the e:2 complex with primer-template DNA using this
new information and published crystal and NMR struc-
tures of the various protein components indicates that the
tether is sufficiently long to bring the exonuclease domain
of e closer to the active site of the  polymerase subunit
when proofreading is required. The model positions two
CBMs on the separate subunits of the 2 clamp, one being
the internal CBM of  and the other the weakly binding
CBM just beyond the C-terminus of the exonuclease
domain of e (25). Mutations of both CBMs for tighter
binding to  produced an e:2 complex that was stable
enough to be isolated chromatographically and used to
collect small-angle X-ray scattering (SAXS) data that are
consistent with the model. NMR measurements showed
that the tether in the eCTS is nevertheless still flexible in
a similar complex. In agreement with the model,
p-benzoyl-L-phenylalanine (Bpa) residues site-specifically
incorporated in 270 were found to afford photo-
crosslinking to the eCTS, in particular at sites located
closer to the active site of the polymerase. The remote
attachment site of e on  via a long flexible tether
suggests that the mechanism for transition between poly-
merization and proofreading modes in Pol III is funda-
mentally different from those in other polymerases whose
structures in both modes are known or can be reliably
modeled (29,30).
MATERIALS AND METHODS
The 15N- and 15N/13C-labeled amino acids and a mixture
of 15N/13C-labeled amino acids were from Cambridge
Isotope Laboratories (Andover, MA, USA). p-Benzoyl-
L-phenylalanine (Bpa) was from Peptech (Burlington,
MA, USA). All other standard reagents required for
cell-free protein synthesis were as described previously
(31,32). New plasmids for overproduction of proteins or
their cell-free synthesis were derivatives of the T7
promoter vectors pETMCSI, pETMCSII or pETMSCIII
(33) and were constructed by standard methods, usually
involving restriction digestion of PCR products and their
insertion between corresponding sites in appropriate
vectors (see Supplementary Methods for full details).
Inserts in all plasmids were confirmed by nucleotide
sequence determination.
In vivo protein expression and purification
The Pol III subunits ,  (9), L and eL (25) and the 2
sliding clamp (34) were purified as described. The LeL
core complex was isolated essentially as described
for wild-type core (25,35). 15N-eL,
15N,13C-e186 and
15N,13C-e193 were expressed in vivo in M9 minimal
medium containing 15NH4Cl and/or
13C-glucose;
15N,13C-e186, 15N,13C-e193 and their complexes with 
were purified essentially as described for e186 and the
e186: complex, respectively (36). The eCTS–270 fusion
proteins (constructs A; Figure 1C) and His6-GL
(Figure 1D) were expressed in vivo and purified as
described in Supplementary Methods. BpaRS was as
described (31). Protein concentrations were determined
spectrophotometrically using calculated values (37) of e280.
Isotope labeling of a270 and a270 or eCTS in the
a270:eCTS complex
Plasmid pKO1367 was used at a concentration of
16 mgml1 for cell-free synthesis of 270-His6 in 0.6ml
reaction mixtures at 30 ˚ C overnight. Five 15N-labeled
270-His6 samples were prepared following the combina-
torial labeling scheme and reaction conditions described
previously (32,38–40). The soluble fraction of 270-His6
was purified using ProPur IMAC Mini Ni-spin columns
(Nalgene Nunc, USA), and the purified protein was
dialysed against 2l of NMR buffer (20mM Tris.HCl, pH
7.0, 150mM NaCl, 1mM EDTA, 1mM dithiothreitol)
Nucleic Acids Research, 2013, Vol. 41, No. 10 5355
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and concentrated to a final volume of about 0.2ml using
Millipore Ultra-4 centrifugal filters (MWCO 10kDa).
D2O was added to a final concentration of 10% (v/v)
prior to NMR measurements. In the same way, five sam-
ples of combinatorially 13C- and uniformly 15N-labeled
270-His6 were made by cell-free synthesis, using the
requisite mixtures of isotope labeled amino acids (41).
For improved sensitivity in the NMR experiments, two
0.6ml reactions were pooled for each sample. Uniformly
13C/15N-labeled 270-His6 was made by cell-free synthesis
in two 0.6ml reactions, using a mixture of labeled amino
acids as described (42).
Plasmid pKO1422 was used at 16 mgml1 for cell-free
synthesis of eCTS (Figure 1B). All samples of the 270-
His6:eCTS complex were purified and prepared for NMR
as described above for 270-His6. One set of five samples
contained combinatorially 15N-labeled 270 in complex
with unlabeled eCTS; they were made by cell-free synthesis
of eCTS in the presence of the combinatorially 15N-labeled
270-His6 samples described above. A second set of five
samples contained combinatorially 15N-labeled eCTS in
complex with unlabeled 270-His6; the eCTS was
produced by cell-free synthesis in the presence of un-
labeled 270-His6, which had itself been synthesized in a
separate cell-free reaction. A third set of five samples con-
tained combinatorially 13C- and uniformly 15N-labeled
eCTS in the presence of separately purified and unlabeled
270-His6. Cell-free synthesis of these five samples used
two 0.6ml reaction mixtures.
NMR spectroscopy
All NMR spectra were recorded at 25˚ C using Bruker 600
and 800MHz NMR spectrometers equipped with
cryoprobes, using 200 ml solutions in 3mm sample tubes.
15N-HSQC spectra used t1max=32ms, t2max=102ms
and total recording times of 1–13 h. 2D HN(CO) spectra
and 3D HN(CO)CA and HNCA spectra were recorded in
20–24 h per spectrum. D2O was added to all samples to a
final concentration of 10% (v/v) prior to NMR
measurements.
Crystallography
The eCTS35–270(L21P) and eCTS44–270(L21P)
proteins were concentrated to 9.5–10mgml1, respect-
ively, by precipitation with ammonium sulfate (0.35 g
ml1); the pellets were dissolved in and extensively
dialysed against 10mM Tris.HCl (pH 7.6), 1mM
EDTA, 1mM dithiothreiotol, 0.1M NaCl. The crystals
used for data collection were grown at 4 ˚ C in sitting
drops with 4.5ml of protein mixed with an equal volume
of reservoir solution of 0.1M Tris (pH 8.4), 0.2M MgCl2,
3mM tris(carboxyethyl)phosphine (TCEP), 16% (w/v)
PEG 3350. Rectangular prisms 300–400mm in length
appeared within 3–4 days. They were cryoprotected by
two transfers (5min each) in reservoir solution supple-
mented with 15% (w/v) PEG 400 before being frozen
for data collection at 100K. X-ray data were collected
on Beamline MX1 [eCTS35–270(L21P)] or MX2
[eCTS44–270(L21P)] at wavelengths of 0.96858 and
0.95369 Å, respectively.
The structure of eCTS35–270(L21P) was solved at
1.7 Å resolution by molecular replacement, using the cor-
responding domain from the reported structure of E. coli
917 (10) as starting model to calculate phase informa-
tion. The structure of eCTS44–270(L21P) was subse-
quently solved at 2.15 Å resolution using the refined
structure of eCTS35–270(L21P) as starting model. Final
models were obtained following cycles of refinement using
REFMAC (43) and manually building using COOT (44).
Data collection and refinement statistics are given in
Supplementary Table S1.
DNA templates for site-directed Bpa mutants of a270
For site-specific incorporation of the unnatural amino
acid Bpa into 270, amber stop codons were engineered
at the corresponding sites of the dnaE(1–270) gene;
primers used are listed in Supplementary Methods. The
first five amber mutations were created by the Phusion
site-directed mutagenesis kit (Finnzymes, Finland), and
the genes were inserted between the NdeI and EcoRI
sites of the T7 promoter vector pRSET-6b (45). The re-
sulting plasmids pKO1481–1485 have the codons of Pro4,
Asp25, Asp75, Gln106 and Lys229, respectively, replaced
by amber codons and were used as DNA templates in cell-
free synthesis reactions. Linear templates for cell-free syn-
thesis of additional amber mutants (codons for Arg175,
Tyr234 and Gln237) were generated by strand overlap
PCR as described (46) using Vent DNA polymerase with
outside primers and pairs of mutagenic primers (see
Supplementary Methods). The PCR products were separ-
ately purified from an agarose gel using NucleoSpin
Extract II kits (Macherey-Nagel, Germany). T7
promoter and terminator sequences were appended in
two further separate PCR reactions (50ml each) (46)
with a mixture of 20–30 ng of purified PCR products
from the previous step. Mixing of two sets of primer
pairs in approximately equimolar ratio, removal of the
residual primers by the NucleoSpin kit, denaturation at
95 ˚ C (5min) and reannealing at room temperature
(5min) yielded DNA with complementary 8-nucleotide
overhangs suitable for cyclization by the intrinsic ligase
activity of the cell-free extract.
Complexes of Bpa mutants of a270 and the eCTS
Cell-free reactions were as described (31,32), with added
Bpa (1mM) and BpaRS (4–15 mM), as required. Plasmid
templates pSH1017, pKO1367 and pKO1422 were used at
16 mgml1 for production of e, 270-His6 and eCTS59
(Figure 1B), respectively. The reannealed amber mutant
PCR products described above were used as template at
10 mgml1. The protein complex between 270-His6
(Bpa mutants or wild-type) and the eCTS were made by
simultaneous cell-free synthesis of the two proteins in the
same reaction mixtures. The 270-His6:e: was produced
by making e in the presence of purified 270-His6 and  or
by co-synthesis of 270-His6 and e in the presence of sep-
arately purified . The complex of 270 with eCTS-Bpa-
His6 was made by cell-free co-synthesis of these partner
proteins in the same reaction mixture. The reaction
mixtures were then clarified by centrifugation (100 000 g,
5356 Nucleic Acids Research, 2013, Vol. 41, No. 10
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1 h) at 4 ˚ C. The supernatants were loaded onto ProPur
IMAC Mini Ni-spin columns and the complexes were par-
tially purified by virtue of the C-terminal His6-tag of 270.
The purified complexes were concentrated to 0.1ml
using Millipore Ultra-4 centrifugal filters (MWCO
10kDa), replacing the buffer with 10mM sodium phos-
phate (pH 6.8), 100mM NaCl, 1mM dithiothreitol for
photo-crosslinking experiments.
Photo-crosslinking and LC-MS/MS analysis of
crosslinked adducts
The isolated wild-type and Bpa-containing protein
complexes (5–8mgml1) were irradiated at 312 nm for
1min using a Mini UV transilluminator system BTS
20M (GAS700X) (UVItec, UK) and subsequently
analysed by SDS-PAGE. The photo-crosslinked 270:e
or 270:eCTS adducts were analysed by LC-ESI-ion trap
mass spectrometry/mass spectrometry (LC-MS/MS) using
a described protocol for in-gel trypsin digestion of gel-
fractionated proteins (47). The solution containing the
tryptic peptides that diffused from the gel pieces was
desalted using C18 Zip-tips (Millipore), dried in a desic-
cator and dissolved in 20 ml of 15% acetonitrile/1% formic
acid for LC-MS/MS analysis using an Agilent 6530
Accurate Mass Q-TOF LC/MS.
Preparation of the His6-aGL:
15N-eL:h complex and
titration with b2
A mixture of 11.0mg of purified His6-GL, 2.7mg  and
5.6mg 15N-eL was treated at 0 ˚ C for 1 h, then dialysed
against 50mM HEPES-KOH (pH 7.5), 300mM NaCl,
20mM imidazole, 5% (v/v) glycerol (buffer A). The
sample (10ml) was separated from excess  and eL on a
5ml Ni-NTA column in buffer A (eluted in a linear
20–500mM imidazole gradient). The His6-GL:
15N-eL:
complex was concentrated to 100 mM in NMR buffer
using Millipore Ultra-15 centrifugal filters (MWCO
10kDa) and stored at 80C. Sample purity was
assessed by 15% SDS-PAGE. 15N-HSQC spectra were
recorded before and after addition of concentrated 2
(separately dialysed in NMR buffer) to 50, 100, 150,
200, 300 and 400 mM (as dimer).
The His6-GL:
15N-eL::2 complex was separately
isolated from a mixture of 100mM His6-GL:
15N-eL:
and 400 mM 2 by gel filtration (Supplementary Figure
S1). The protein complex was concentrated to about
40 mM in NMR buffer using Millipore Ultra-4 centrifugal
filters (MWCO 10kDa) and stored at 80 ˚ C.
NMR titration of 15N,13C-e:h complexes with b2
Complexes of 15N,13C-e186 and 15N,13C-e193 with
purified unlabeled  were dialysed into NMR buffer and
concentrated using Amicon Ultra-4 centrifugal filters
(MWCO 10kDa, Millipore). Resonances in the
15N-HSQC spectra of e186 and e193 in the two complexes
with  were assigned by reference to previous assignments
of e186 in e186: (BioMagRes database entry: bmrb6184),
our e assignments in the e complex (9) and new experi-
mental data for residues Ala188, Gln182–Ala186 and
Thr193 obtained from 2D HN(CO) spectra and 3D
HN(CO)CA and HNCA spectra. Phe187 was assigned
through combinatorial labeling with 15N and 15N/13C to
identify the Ala186–Phe187 dipeptide. The assignment of
resonances in the CBM of e193 (Gln-Thr-Ser-Met-Ala-
Phe) were confirmed using cell-free residue-specific
15N-labeling of wild-type and two CBM mutants of
e193, that is, eL193 (CBM: QLSLPL) and eQ193 (CBM:
ATSMAF) (25), with these six amino acids, and of eL with
15N-Leu, all in the presence of excess unlabeled .
NMR titration of the 15N,13C-e186:  complex (100mM)
with 2 was made by recording of
15N-HSQC spectra
before and after progressive addition of concentrated
purified 2 to 100, 200, 300 and 400mM, whereas the
15N,13C-e193: complex (34mM) was similarly titrated
with 34 and 68 mM 2. Spectra were also recorded of the
15N-Gln, Thr, Ser, Met, Ala, Phe labeled e193:unlabeled 
(27mM) sample with and without added 2 at 30 mM.
Small-angle X-ray scattering
A mixture of the LeL core (1mg) and 2 (2mg) was
dialysed into buffer C (50mM Tris.HCl pH 7.6, 1mM
EDTA, 1mM dithiothreitol, 10% v/v glycerol) containing
100mM NaCl. The stoichiometric LeL:2 complex was
separated from excess 2 by anion exchange chromatog-
raphy on a MonoQ 5/50 GL column (GE Healthcare)
using a gradient of 0.1–1.0M NaCl in buffer C,
concentrated to 2.15mgml1 using an Amicon Ultra
0.5ml centrifugal concentrator (Millipore) and stored
frozen at 80 ˚ C. SDS-PAGE was used to confirm the
presence of all four subunits.
Scattering data were recorded on the SAXS/WAXS
beamline at the Australian Synchrotron. The complex
was analysed by size-exclusion chromatography-coupled
small-angle X-ray scattering (SEC-SAXS). The complex
was dialysed into 50mM Tris.HCl pH 8.0, 0.1M NaCl,
1mM EDTA, 1mM TCEP, 5% (v/v) glycerol and 70 ml
were injected at 0.5mlmin1 onto a Wyatt WTC-030S5
SEC column (7.8 300mm) equilibrated at 12 ˚ C in the
same buffer. A280 of the eluate was monitored immediately
prior to its passage through a quartz capillary that was
illuminated by a collimated 11 keV X-ray beam,
l=1.127 Å. Scattering from the sample was measured
by a Pilatus 1M detector (Dectris, Switzerland) that
recorded 2D scattering images in 2 s exposures from a
position 3349mm behind the sample. For all the frames
used for the data analysis, no protein damage induced by
X-rays was observed. Scattering from the eluate was stable
as averaged from 10 exposures prior to and after elution of
protein, to give the buffer scattering. Following radial
averaging and buffer subtraction, the radii of gyration,
Rg, of five exposure bins were determined by Guinier
analysis using AUTORG (48) and plotted against
elution volume. Sample scattering was averaged across
the region of Rg stability, which corresponded to the
main UV absorption peak in the elution profile and en-
compassed 20 exposures. The scattering pattern was
truncated within the range 0.012Q 0.16 Å1. The the-
oretical SAXS patterns, radii of gyration and envelope
volumes of various atomic models were calculated using
CRYSOL (49), for comparison with experimental results.
Nucleic Acids Research, 2013, Vol. 41, No. 10 5357
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RESULTS
Cell-free but not in vivo expression of the PHP domain of
a yields correctly folded protein
As full-length E. coli  is prone to proteolysis and is un-
suitable for crystallization (10), we studied the interaction
between domains of  and e. It had been shown that the
N-terminal 320-residue fragment of  binds e (19), but the
PHP domain of  defined subsequently ends already at
residue 270 (10). However, a soluble construct comprising
the N-terminal 270 residues (270) produced in vivo
appeared to be unfolded as indicated by the 15N-HSQC
NMR spectrum of a 15N-labeled sample (Supplementary
Figure S2A). In contrast, samples made by cell-free
protein synthesis routinely showed a chemical shift disper-
sion characteristic of a well-structured globular domain
(Supplementary Figure S2B). Therefore, we subsequently
produced all samples of 270 by cell-free synthesis.
Coarse mapping of the interface between a270 and the
eCTS by NMR
Expression of a construct comprising the flexible 59
C-terminal residues of e preceded by a 22-residue tag
(eCTS59; Figure 1B) in the presence of
15N-labeled 270
led to a soluble complex that retained the overall chemical
shift dispersion of 270 with some significant chemical
shift changes, as expected for specific binding
(Supplementary Figure S3A).
We also used NMR spectroscopy to map the binding
site of the eCTS on 270. As the stability and concentra-
tion of 270 samples was insufficient for conventional
triple-resonance NMR experiments, combinatorial
labeling was used to obtain resonance assignments
(38,39). Five samples were prepared, in which different
residues of 270 were labeled with 15N in different com-
binations (Supplementary Figure S4A and B), allowing
the residue-type identification of the 15N-HSQC cross-
peaks. In addition, five samples were prepared with com-
binatorial 13C-labeling and uniform 15N-labeling. 2D
HN(CO) NMR spectra of these samples provided the
residue-type information of the preceding amino acid for
each 15N-HSQC cross-peak (Supplementary Figures S3B
and S4C) (50). In combination, the 10 samples provided
sequence-specific resonance assignments for 50 15N-HSQC
cross-peaks arising from amino acid pairs that are unique
in the sequence of 270 (Supplementary Table S2).
A second set of five combinatorially 15N-labeled
samples of 270 was prepared in complex with unlabeled
eCTS59 and
15N-HSQC spectra were recorded (data not
shown). Significant chemical shift changes occurred
throughout the 270 domain, but the two largest were
observed for amides within 15 Å of its N- and
C-terminal ends (Supplementary Figure S3). This
indicated that in contrast to 270, a fusion construct of
it with the eCTS could be a stable, well-folded protein.
The 15N-HSQC spectrum of the 15N-eCTS59 construct
in complex with unlabeled 270 displayed many narrow
lines, indicating that much of it is highly mobile and not
tightly interacting with 270. For resonance assignments,
eCTS59 in the complex with unlabeled 270 was
combinatorially 15N-labeled (Supplementary Figure S5A)
and, in a second set of five samples, labeled combinator-
ially with 13C and uniformly with 15N. 3D HNCA and
HN(CO)CA experiments with the second set were used
to assign most of the flexible amino acid residues in the
eCTS59 construct. Like 2D HN(CO) experiments, the 3D
HN(CO)CA spectra of the combinatorially labeled
samples identified for each 15N-HSQC cross-peak the
amino acid-type of the preceding residue. In addition,
the HN(CO)CA spectra delivered its C chemical shift
which, together with the HNCA spectrum, provided
more secure resonance assignments than could have
been obtained from a single uniformly 15N/13C labeled
sample. The final resonance assignments corresponded
to the segment from Phe187 to Ala209. In addition, two-
thirds of the residues of the non-native N-terminal
22-residue tag of the eCTS59 construct were assigned in
the complex (Supplementary Table S3). The narrow line
widths and random coil chemical shifts of these residues
indicate high flexibility as expected. Most notably, no
signals could be observed for the C-terminal segment
(Ser210 to Ala243) of the eCTS, except for the amides of
Glu221 and Gly237, indicating immobilization by tight
association with 270. The delineation of the flexible
residues in the eCTS was used to design fusion constructs
of the eCTS with 270.
Crystal structures of intramolecular a270–eCTS
complexes
The 270 domain was fused to the eCTS (residues
209–243) via a nine-residue linker, where the eCTS was
N-terminal of 270 in construct A and C-terminal of
270 in construct B (Figure 1C). To assess the impact of
the fusion on the structural integrity of 270, we
compared the 15N-HSQC spectra of selectively
15N-alanine labeled samples of constructs A and B with
corresponding spectra of the similarly 15N-alanine labeled
non-covalent 270:eCTS59 complex. All samples were
readily produced in soluble form by cell-free synthesis.
The NMR spectrum of construct A was much more
similar to the spectrum of the 270:eCTS59 complex
than the spectrum of construct B (Supplementary Figure
S6A and B), suggesting that construct A is a stable intra-
molecular 270:eCTS complex.
Both constructs were expressed in vivo, and could be
purified in soluble form for use in crystallization trials,
but neither yielded crystals. Crystals were obtained,
however, for a variant of construct A that contained a
fortuitous point mutation in the 270 domain,
Leu21Pro. Some of the cross-peaks were broad or
missing from the 15N-HSQC spectrum of the
15N-alanine labeled mutant protein, suggesting conform-
ational exchange broadening of some of the NMR signals
(Supplementary Figure S6C and D). The crystal structure,
however, shows no evidence of conformational heterogen-
eity, which may be explained by crystal contacts involving
Pro21 leading to preferential crystallization of a particular
conformer; in all four molecules in the asymmetric unit,
Pro21 makes a crystal contact with an alanine residue.
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The 1.70 Å crystal structure of the (Leu21Pro) mutant
of construct A was solved by molecular replacement using
the 270 domain from the structure of 917 (PDB: 2HQA)
(10) as starting model (Supplementary Table S1). The four
molecules in the unit cell show a maximum C RMSD of
0.284 Å in pairwise alignments, and in all four the struc-
ture is fully ordered from Lys211 of eCTS (numbered
throughout as in full-length e) through the linker region
and the entire -PHP domain to the final residue, Thr270.
In one of the monomers, the backbone and side chain C
of Ser210 is also ordered, and in another Lys211 has al-
ternate side chain conformations.
The refined structure of the eCTS35–270 protein shows
the eCTS assuming an extended structure across one face
of 270, followed by an -helix. The C-terminal residues
that follow are located in a pocket formed by 270 and the
-helix of the eCTS (Figure 2). The eCTS portion is fully
structured and in contact with  between residues Lys211
and the C-terminus of e; electrostatic and H-bonded
contacts between  and e are listed in Supplementary
Table S4, and these are complemented by a much larger
number of hydrophobic interactions. Although it is
engaged in crystal contacts, the linker peptide connecting
the eCTS with the 270 domain is solvent exposed, so that
the structure of the complex is unlikely to be affected by
its length or conformation. The mutated residue Pro21 of
270 is far removed from the eCTS binding region on the
opposite face of the PHP domain (Figure 2A) that is in
closer proximity to the polymerase active site in the 917
structure (10).
To confirm the NMR data that eCTS in complex with
270 is indeed unstructured in the linker preceding
Ala209, we made a longer type A fusion construct
commencing at Ala200 (i.e., eCTS44–270), crystallized it
under similar conditions, and solved its structure at 2.15 Å
(Supplementary Table S1). In two of the four chains in the
asymmetric unit, residues preceding Lys211 were still
disordered, but in one of the other two, weak electron
density was interpreted as the tetrapeptide segment
Ile202–Ile205 that has additional interactions with the
region around His183 and Asp252 of 270 (Figure 2
and Supplementary Table S4), and Ser210 was also
fully ordered. Because the Val206–Ala209 segment is
A proofreading domain 
(ε186), binds θ
                GQTSMAFAMEGETQQQQGEATIQRIVRQA
SKLRVVFATDEEIAAHEARLDLVQKKGGSCLWRA
CBM
εCTS
Q-linker
flexible in αεθ complex
structured in complex with α270
181 201191
211 221 241231
B εCTS :59
MASMTGGLNDIFEAQKIEWHEH-MAFAMEGETQQQQGEAT
IQRIVRQASKLRVVFATDEEIAAHEARLDLVQKKGGSCLWRA
185 200190
210 230 240220
Construct A:  εCTS   (209–243)-TRESGSIGS-α270(1–270)
εCTS   (200–243)-TRESGSIGS-α270(1–270)
Construct B: α270(1–270)-TRESGSIGS-εCTS   (209–243)
C
D
internal
CBM
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Val832
PHP domain (α270)
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35
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35
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* *****
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flexible in αεθ:β  complex
* *** * *
2
*flexible in α270:εCTS    complex59
*** * ** **** *** *** ** ***
Figure 1. Protein constructs used in the present work. (A) The e
subunit is the proofreading 30–50 exonuclease of Pol III. It binds
tightly to the  subunit via its C-terminal segment (eCTS). The
globular domain of e, e186 (12) binds to the y subunit (15,16). The
eCTS comprises residues 181–243, including the  CBM at residues
182–187 (in red); the quadruple-mutant T183L/M185L/ A186P/F187L
(eL) has a strengthened CBM (25). The -binding site lies in the
C-terminal part of the eCTS. At least 19 residues between e186 and
the -binding site (i.e., between Thr183 and Thr201) remain flexible in
the e complex; Ala and Thr residues for which flexibility was estab-
lished are indicated by asterisks (9). We refer to the segment comprising
residues 190–209 (in orange) as the Q-linker (21). The present work
reports: (i) that residues between Phe187 and Ala209 of eCTS
(indicated by asterisks) remain flexible in the complex of eCTS59 and
the PHP domain of , a270 (Supplementary Table S3); (ii) the 3D
structure of the complex between the eCTS (in purple) and the PHP
domain of  (Figure 2), showing that part of the -binding segment of e
forms a helix (residues 218–237) upon binding; and (iii) that residues
between Glu190 and Arg204 (indicated by asterisks) remain flexible in a
stabilized mutant version of the e:2 complex (Figure 4). The
C-terminal residues of the e186 and e193 constructs are indicated.
(B) Amino acid sequence of the eCTS59 construct. Residues 185–243
of e are labeled with the sequence numbers of full-length e. The
preceding residues in italics are not part of e; they comprise a T7
gene 10 tag (resulting in the N-terminal peptide MASMTG) for
improved cell-free expression yields and a biotinylation site. (C) The
Figure 1. Continued
first 270 residues of  (270) contain the PHP domain. To determine
the 3D structure of the eCTS in complex with 270, eCTS35 (residues
209–243) or eCTS44 (residues 200–243) was fused to either the
N-terminus (constructs A; eCTS35–270 and eCTS44–270) or the
C-terminus (construct B; 270–eCTS35) of 270. The amino acid
sequence of the nine-residue linker is similar to one that had been
determined to be flexible in another context (27,28). (D) Purification
of the e:2 complex is difficult due to the limited affinity of 2 for the
e core. Increased affinity between  and 2 (for SAXS measurements)
was achieved by changing residues 920–924 (internal CBM) from
QADMF to QLDLF (26) to produce a mutant we refer to as L
(25), and then (for NMR measurements) introducing a further
Val832Gly mutation (25,54) to yield GL; GL also contains an
N-terminal His6 tag for purification. The figure shows the sites of
Val832 and the internal CBM plotted in blue on the structure of the
 subunit from T. aquaticus (11). The PHP domain is shown in orange
and the Mg2+ ion in the active site in magenta.
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disordered, we are unable to tell if this eCTS tetrapeptide
derives from the same molecule to which it is bound, or
from a neighboring molecule in the crystal lattice, and the
NMR data show that this segment is inherently flexible in
solution. Although it seems probable that these additional
interactions are rather transient in the context of the full
e core complex, they nevertheless indicate where in
space the flexible segment of e (between Ala188 and
Ala209) is likely to reside, at least in the closed form of
the e:2 complex during DNA synthesis (25).
The PHP domain of  in the crystal structures of con-
struct A and in 917 (10) is fully conserved structurally,
except around the site of the Leu21Pro mutation, with a
backbone RMSD of 0.532 Å over 253 C atoms. This
allows straightforward modeling of the eCTS onto the
structure of 917. As discussed in detail below (see also
Supplementary Movie S1), the C-terminus of e binds to 
in a position that would place the extended peptide
segment immediately preceding the C-terminal helix of e
and the exonuclease active site far from that of the poly-
merase. Its unusually remote location raises questions
about how the N-terminal exonuclease domain of e
gains access to a mismatched primer terminus when proof-
reading is required. Thus, we sought to obtain further in-
formation about the location in the complex with  of the
linker peptide that extends in e from the CBM (i.e., from
Ala188) to the structured part in the crystal structures
above.
Photo-crosslinking to localize the flexible peptide segment
of the eCTS on a270
In agreement with the NMR evidence for high mobility of
residues prior to Ala209, the crystal structures of eCTS in
the two type A constructs showed consistent electron
density only from Lys211 onwards. To explore the
location of the flexible residues of the Q-linker, we
introduced the unnatural amino acid p-benzoyl-L-phenyl-
alanine (Bpa) at different sites in 270, using the orthog-
onal Methanococcus jannaschii system developed by P.G.
Schultz and co-workers, where the site of Bpa incorpor-
ation is encoded by an amber stop codon (51). The puri-
fication of the mutants was facilitated by producing the
protein in a cell-free system, which relied on purified
plasmid DNA with amber stop codons, purified Bpa-
tRNA synthetase and a total tRNA preparation that con-
tained the amber suppressor tRNA (31). Most Bpa
mutants were produced in yields of up to 1.5mgml1 in
7 h without evidence of truncation at the amber stop
codon (Supplementary Figure S7A). Full-length proteins
were readily purified using a Ni-NTA spin column, as all
270 mutants carried a C-terminal His6-tag. The produc-
tion of the Ala25Bpa mutant, which was initially ex-
pressed in low yields, was improved dramatically by
using the optimized (52) amber suppressor tRNAopt and
doubling the amount of total tRNA (31).
Cell-free expression of e in the presence of the purified
Bpa mutants of 270 and of separately purified 
produced stable soluble complexes that could be purified
as shown previously for wild-type  (9). Similarly, soluble
complexes of the 270 Bpa mutants with the eCTS59
construct were obtained by cell-free co-expression of the
270 mutants and of eCTS59 (Supplementary Figure
S7B and C).
UV irradiation (312 nm, 1min) effects photo-
crosslinking of Bpa to nearby residues (<3 Å) (53). SDS-
PAGE revealed crosslinking with full-length e when Bpa
A
B
αL21P
εI202
εI205
K211
αT270
εA243
linker
αM1
I202
I205
Q203
R204
H225
A223
E220A227L231
R228
L240
G237
A243
T218
A217
R213
V215
K235
S210
S210ε
εT218
εG237
εK211
Figure 2. 1.7 Å crystal structure of construct A (eCTS35–270) with the
Leu21Pro mutation in 270. In the ribbon diagram in (A), eCTS35 and
270 are in green and cyan, respectively, while the nine-residue linker
between the eCTS and 270 is in yellow. The location of residue 21 (in
magenta) and the N- and C-termini of 270 (M1, T270) are
indicated. The eCTS35 region is fully structured from Lys211–Ala243,
and forms an -helical segment between Thr218 and Gly237. The
additional contacts of residues Ser210 and Ile202–Ile205 of eCTS
with 270 in the 2.15 Å structure of eCTS44–270(L21P) are also
indicated. (B) A view in the same orientation with 270 in space-
filling representation (gray) and side chains of selected residues of
eCTS (green) shown as sticks (green). Residues Ser210 to Ala217
of eCTS form an extended structure that lies in a groove in 270. A
list of H-bonding and electrostatic contacts between residues in  and e
is given in Supplementary Table S4.
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was located in positions 19, 21, 23, 25 and 229 of 270, but
no crosslinks were observed with Bpa at positions 4, 75
and 106 (Supplementary Figure S7B and data not shown).
Mass spectrometric analysis of in-gel tryptic digests con-
firmed that the crosslinks were with the eCTS rather than
the globular N-terminal domain of e. Additional experi-
ments were carried out with the eCTS59 construct to elim-
inate the need to exclude binding to the N-terminal
domain of e. Bpa mutants at positions 175, 229, 234 and
237 displayed crosslinks with eCTS59 (Figure 3;
Supplementary Figure S7C). The wide distribution of
crosslinking sites across the surface of 270 confirms the
NMR observation of high flexibility in the linker segment
of e before the C-terminal 270-binding region. Most
interestingly, the Lys229Bpa mutant readily crosslinked
with a peptide segment preceding Gln196 in eCTS59
(Supplementary Figure S8), although Lys229 is located
on the opposite face of the PHP domain compared to
the binding site of the C-terminus of e. Therefore, the
Q-linker region of the eCTS readily wraps around the
PHP domain of  but is not poised for specific binding
interactions with the PHP domain.
Photo-crosslinking experiments between 270 and the
eCTS were also conducted with an eCTS construct that
was extended at its C-terminus by Bpa-His6. MS analysis
of a tryptic in-gel digest of the cross-linked complex
revealed linkage to the segment of residues Ala31–Lys52
in  (data not shown). This result is in agreement with the
crystal structure, which positions the peptide linker
between the eCTS and 270 within 11 Å of the peptide
identified by MS.
The eCTS Q-linker remains flexible in the aeh:b2 complex
The e subunit harbors a CBM immediately following the
exonuclease domain (i.e., residues 182–187) (25), and 
also contains a CBM between residues 920 and 924 (24).
Although each binding interaction is individually weak,
the cooperativity of binding of  to one subunit of the
2 dimer and of e to the other maintains the integrity of
the e:2 replicase complex with DNA during highly
processive DNA replication (25). The questions remain
whether such a binding arrangement is compatible with
the available structural information on the replisome
subunits and whether the eCTS can accommodate this
arrangement. To investigate the structural confinement
of the eCTS in the e:2 complex, we studied the NMR
spectrum of the GLeL:2 complex, where GL and eL are
mutants of  and e with improved binding affinities to 2
(Figure 1A and D); in addition to strengthening mutations
in the CBM (as in L) (25,26), GL also contains an add-
itional mutation (Val832Gly; spq-2) (25,54) that by itself
strengthens binding of e to 2 (S.J. and Thitima
Urathamakul, unpublished). For example, a peptide
with an optimized CBM as in eL interacts about 500-fold
more strongly with 2 than the wild-type CBM of e (25),
while the L mutations (A921L, M923L) in the CBM of 
strengthen binding to 2 120-fold (26). For NMR meas-
urements, GLeL was made with uniformly
15N-labeled eL
and mixed with a 3-fold excess of 2; the stoichiometric
GLeL:2 complex was stable enough to be isolated by gel
filtration (Supplementary Figure S1).
The molecular mass of the GLeL and GLeL:2
complexes is so high (165 and 245 kDa, respectively) that
only highly mobile peptide segments can generate cross-
peaks in 15N-HSQC spectra. Remarkably, almost all the
cross-peaks that could be observed for the GLeL
complex (Figure 4A and Supplementary Figure S5B)
could also be observed in the presence of 2 (Figure 4B
and C), although with generally decreased intensity as
expected for the slower overall tumbling rate of the
GLeL:2 complex (Supplementary Figure S9). The
peaks did not arise from complexes with sub-stoichiomet-
ric amounts of 2, as they were observed even in the
presence of an excess of 2. Assignments for many of
these resonances (residues Glu190–Thr201 and Arg204)
were obtained by comparison with spectra of 270 in
complex with 15N-labeled eCTS (Figure 4B), and
indicate that the Q-linker is clearly still mobile when the
CBM of e is tied to the 2 clamp.
The e subunit interacts with b2 only through the CBM
Identification of the role of the CBM just following the
structured domain of e in DNA replication (25), when
combined with the structure of the eCTS in complex
with the -PHP domain (Figure 2) enables us to position
the proofreader between the 2 clamp and PHP domain of
 in the e:2:DNA complex in the polymerization mode
of DNA synthesis (25). We have previously shown by
NMR that e186 does not interact, even weakly, with 
(9), and we now asked if e contains a second site for
229
175
75
2321
234
19
106
237
25
Figure 3. Sites in 270 where Bpa residues were introduced for photo-
crosslinking with e to detect proximity to residues for which no struc-
tural information was obtained by the crystal structure in Figure 2. The
location of the eCTS determined by the crystal structure is shown in
yellow, with the nine-residue linker peptide in green. The C atoms of
residues at sites leading to efficient, less efficient or no crosslinking are
highlighted in red, magenta and cyan, respectively.
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interaction with 2 that orients it precisely in the e:2
complex. To do this, we made a new truncated version of e
we call e193 (residues 2–193), that contains all of the
structured exonuclease domain and the CBM
(Figure 1A). We first used cell-free synthesis to prepare,
in the presence of excess unlabeled , a sample of e193
(27mM) that was 15N-labeled only with amino acids that
comprise the CBM (Gln, Thr, Ser, Met, Ala and Phe), and
assigned these residues in the 15N-HSQC spectrum of the
whole e193 protein as described in Materials and Methods
section. Addition of 2 to 30 mM led to disappearance of
signals corresponding to all residues of the CBM (Gln182–
Phe187), but no significant changes to the spectrum of the
structured proofreading domain or of Ala188 and Thr193
in the region beyond the CBM (Figure 5). These data are
the first to directly show the interaction of the CBM in e
with 2 at single-residue resolution.
We also isolated the complex of uniformly in vivo
15N,13C-labeled e193 with unlabeled , and recorded its
15N-HSQC spectra (at 34 mM) in the absence and
presence of 2 at 34 and 68 mM (data not shown). Once
again, the only cross-peaks broadened beyond detection in
the e193 spectrum were those in the region of the CBM;
peaks throughout the remainder of the spectrum did not
shift and were only broadened at the highest concentra-
tion of 2, consistent with the exonuclease domain being
freely mobile in the complex with 2, except in the CBM
that interacts directly with the clamp. In further support
of the conclusion that e contains no site of interaction with
2 beyond the CBM, we were unable to detect any signifi-
cant changes in the 15N-HSQC spectrum of 15N,13C-e186:
(100 mM) on addition of up to 400mM 2.
Structural modeling of the Pol III replicase complex in
the polymerization mode
The 3D structures of many components of the Pol III
replicase complex are known from different bacterial
sources, including three crystal structures of Pol III : of
E. coli 917 (10), and of full-length Taq  alone (11) and in
complex with primer-template DNA (55). The DNA-free
protein structures are remarkably similar and reveal an
open state that closes on binding primer-template DNA
(discussed in 25). In addition, the crystal structures of an
E. coli 2:dsDNA complex (23), e186 (12) and the
e186:HOT complex (13,14) are known, as well as the
NMR structure of the e186: complex (16).
Combining these atomic-resolution structures with
the present structure of the 270:eCTS complex and the
identification of CBMs in  (24,26) and e (25), we initially
built a compact model of the replicase complex in the
polymerization mode with the e186 and  domains in
available space between the  clamp and the -binding
domain of  (Figure 6A, Supplementary Movie S1 and
Supplementary Pymol Session File S1; model building
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T193
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Figure 4. A large segment of the eCTS remains flexible in the GLeL:2 complex. The mutant subunits GL and eL were used in the complex to
avoid dissociation of 2 during purification using the N-terminal His6 tag on GL. (A)
15N-HSQC spectrum of the GLeL complex with
15N-labeled
eL. Only amides from mobile residues are observable in the 165 kDa complex. (B)
15N-HSQC spectrum of the GLeL:2 complex with
15N-labeled e.
Resonance assignments obtained by comparison with spectra of 270 in complex with 15N-labeled eCTS are indicated. Most if not all of the
observable peaks can be attributed to the eCTS. The same set of amides from mobile residues is observable in the purified 245 kDa complex as
in (A). The spectrum was recorded using a 0.1mM solution of the complex at 25 ˚ C. (C) Superimposition of the spectra in (A) and (B) demonstrates
that most chemical shifts remain conserved.
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is described in Supplementary Methods). This model
fulfils all the known restraints, including the current
results that the Q-linker region in e is flexible and at
least transiently close to Lys229 in  (Figure 3), and that
residues 202–205 of e are transiently close to His183 and
Asp252 of  (Figure 2). In the model, the CBMs of  and e
bind to different subunits of 2 and the exonuclease
domain of e readily approaches the DNA, while the
conformational space available to the Q-linker of e is
sufficiently large to allow high mobility (Figure 6A).
Since we have been unable to detect an additional point
of contact of e with either  (9) or  (above), it may be that
either (i) the globular e186 domain remains mobile in the
complex (it can still rotate in its position in this model
without clashing with 2 or ) or it is held in a fixed
position through transient electrostatic contacts with
the double-stranded portion of the primer-template
DNA. Its precise position could potentially be defined
by further crosslinking studies, but we note that as with
our Bpa data, all crosslinking methods are inherently
unsuitable for precise definition of positions of compo-
nents of intrinsically dynamic complexes; they dem-
onstrate where subunits can be, not where they
necessarily are.
A third possibility is that the exonuclease domain
remains much more freely mobile in the complex during
DNA synthesis, and is reoriented to an appropriate
position during proofreading. The structured region of
e186 ends at Gly180 and Gln182, the first residue of the
CBM, is bound in the protein-binding groove of 2.
Although the closeness of these residues restricts the
space that can be occupied by e, it is still possible for e
to rotate away from :2 to produce less compact and
more mobile structures.
Assessment of structural models using SAXS data
The LeL:2 complex, with both the CBMs in  and e
strengthened, has been observed to be stable by ESI-MS
under native conditions (25), and as with the correspond-
ing complex containing GL, it can be isolated chro-
matographically (see Supplementary Methods). To assess
whether the L subunit in this stabilized replicase complex
has a closed structure similar to that in our model
(Figure 6A) even in the absence of primer-template
DNA, we collected real-time gel-filtration SAXS data on
the LeL:2 complex at a synchrotron source (Figure 7)
and compared it with predicted scattering curves for
various structural models.
Analysis of the data showed good agreement with the
overall dimensions of an initial docking model with a
closed  conformation, but indicated too compact
packing of the e subunits to the  chain (Figure 7B).
An ensemble of 1000 alternate structures was generated
by allowing free rotation around the backbone dihedral
angles of Gly180–Gln182 in e while disallowing steric
clashes with :2 (Figure 6B, Supplementary Movie S2
and Supplementary Pymol Session File S2). Averaging
over the ensemble resulted in a markedly improved fit
of the SAXS data at Q-values in the range of
0.07–0.12 Å1 (Figure 7), which suggests that e is not
restrained in a single conformation in the stabilized
e:2 complex, at least in the absence of primer-
template DNA.
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Figure 5. Isotope labeled e193 in complex with purified unlabeled  interacts with 2 only through the CBM. Superimposition of
15N-HSQC spectra
of uniformly in vivo 15N,13C-labeled e193:unlabeled  (black spectrum, selected resonance assignments in black) and of e193: (27 mM) labeled
specifically in e193 with 15N-glutamine, threonine, serine, methionine, alanine and phenylalanine in the absence (blue spectrum) and presence (red
spectrum) of 2 (30 mM). Resonances were assigned as described in Materials and Methods. Cross-peaks were observed for 52 of 59 Gln, Thr, Ser,
Met, Ala and Phe residues in the structured e186 domain, and all were unaffected by addition of 2 (selected signals labeled in purple); those of Ser2
and Thr3 in the disordered N-terminus could not be assigned, while Ala100, Thr128, Ser144, Ala164 and Thr179 had low intensity even in the
absence of 2. Signals in the CBM that broaden beyond recognition in the presence of 2 (red spectrum; i.e., Gln182, Thr183, Ser184, Met185,
Ala186, Phe187) are labeled in green, while assignments for flexible residues at the N- and C-termini (Ala4, Ala188 and Thr193) that are unaffected
by 2 are labeled in orange.
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DISCUSSION
The crystal structure of the 270:eCTS complex solved in
the present work allows, for the first time, the building of
informed models of the e:2 replicase complex with
primer-template DNA in the polymerization mode
(Figure 6A). The high-affinity binding site of the eCTS
on the PHP domain of  turned out to be surprisingly
remote from the active site of the polymerase. The long
Q-linker of e was found to be highly mobile even in the
context of the e:2 complex, readily accommodating a
conformation that allows the CBM located in e near the
C-terminus of the globular exonuclease domain (25) to
bind to the well-established protein-binding site of . It
is intriguing to speculate that the exonuclease could
swing a long distance from the DNA when its CBM is
released from the 2 clamp. Release of the e CBM from
2 would be a requirement for entry of other -binding
proteins, including repair and translesion polymerases
(56) into the replicase complex, and might also occur in
the transition from polymerization to proofreading
modes (25). The distance between the polymerase and
exonuclease active sites in all model structures in
Figure 6 is >70 Å (average of 92.3 Å for the ensemble
in Figure 6B); that this distance is so large suggests it is
very likely that the e– contact is broken during transi-
tion to the proofreading mode, to allow  to assume a
more open structure and access of e to the mismatched
primer terminus. To compensate for the loss of binding
affinity of the CBM, the conformational change in 
could expose a cryptic-binding site for the e186 domain
(or ), such that the exonuclease site is appropriately
positioned for proofreading. In this scenario, binding of
α-PHP in
construct A
θ
ε
β (ε CBM)
β (α CBM)
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ε C-terminal
segment
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α C-terminal
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α β-binding
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ε N-terminus
ε β-binding
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90˚
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Figure 6. Models of the e:2 complex with primer-template DNA in
the polymerization mode. Color coding:  (blue), with the PHP domain
of the crystal structure superimposed in red, e (yellow),  (orange) and
2 (subunit in cyan contacting the CBM of e and that in magenta
contacting the internal CBM of ). (A) Compact structure of a form
of the ‘closed’ complex (25) with e sandwiched between the  clamp
and the PHP domain of . Multiple conformations are displayed for
the 22-residue linker segment connecting the -bound portion of the
eCTS with the globular exonuclease domain of e (e186) that was pos-
itioned to bring its CBM in proximity to the protein-binding groove of
. All conformations of the linker segments are sterically allowed,
explaining the high mobility observed in this segment experimentally.
(B) It is possible to rotate e out of the complex into a more open
structure while maintaining its contacts with the PHP domain of 
and 2. Multiple (other) sterically allowed exonuclease domain (e)
conformations are displayed; these represent a subset of the structures
used to back calculate scattering curves in Figure 7. The view on the
left is the same as in (A); that on the right is rotated 90 ˚ as indicated.
A
R
g , Å
 (       )
0
20
40
80
60
100
0
20
40
80
60
10
3 
.A
28
0
( 
   
   
)
elution volume, ml
1098 1176
I(0)
B
1e−05
0.0001
0.001
0.01
0 0.05 0.10 0.15
In
te
ns
ity
, c
m
–1
Q, Å–1
Experimental
Average theoretical scattering of 1000 αεθ:β  models 
Theoretical scattering of loose αεθ:β  model 
Theoretical scattering of compact αεθ:β  model 
2
2
2
Figure 7. SEC–SAXS measurement of LeL:2 complex. (A) Elution
profile showing the A280 (black continuous line) and SAXS data
including the forward scattering intensity I(0) (green-dashed line) and
Rg (in blue) calculated by Guinier analysis of five-exposure bins; values
of I(0) vary linearly between 0.0007 and 0.0105 cm–1. To obtain the
experimental SAXS pattern, exposures were averaged in the region of
Rg stability (bounded by vertical red bars) before data reduction and
buffer subtraction. (B) Experimental SAXS data for the LeL:2
complex (scatter plot), for which the pair distance distribution (not
shown) indicates Rg=48.8±0.2 Å and maximum dimension of
152.5 Å. For comparison, the averaged theoretical scattering of 1000
e:2 models generated by free backbone rotation in segment e180–182
(Figure 6B) is shown in red; these models have mean Rg=47.6 Å and
mean envelope diameter of 154.2 Å. The theoretical scattering of a
typical e:2 model with a more open (loose) orientation of e is
shown in blue; Rg=48.3 Å, envelope diameter=152.9 Å, and that of
an e:2 model with a compact orientation of e is shown in green;
Rg=46.8 Å, envelope diameter=151.5 Å.
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e186: to either the 2 clamp or to  would present a
switch between the two modes that is fundamentally dif-
ferent from that observed in simpler polymerases with an
integrated proofreading domain, where the transition
between polymerization and proofreading modes
requires protein-mediated transfer of the 30 end of the
primer over a distance of 20–30 Å between the polymer-
ase and exonuclease active sites (29,30). In contrast, re-
positioning of the exonuclease domain of Pol III over a
sufficiently large distance is perfectly conceivable, as the
e186 domain does not interact to any appreciable degree
with the eCTS,  or, as shown here, to  (9).
Proofreading would still require disengagement of the
mismatched primer-template from the polymerase active
site and sliding back of the ds DNA portion through the
2 clamp to allow access of the 3
0 primer terminus to the
exonuclease active site.
On a technical note, cell-free protein synthesis proved to
be a decisive tool in this project, as 270 folded into a
defined conformation when expressed by cell-free synthe-
sis but not when it was produced in vivo. Furthermore,
overexpression of full-length e in vivo leads to insoluble
protein, which in the past could only be solubilized by a
denaturation and refolding protocol (57). Cell-free synthe-
sis of e in the presence of its natural-binding partners  and
, however, circumvented this problem, readily yielding
the stable ternary e complex (9). Similarly, eCTS59
when expressed by itself was insoluble, but soluble
complexes with 270 and mutants thereof were readily
obtained by cell-free synthesis. Furthermore, this
approach allowed efficient 15N-labeling of individual
proteins in selective (58,59) and combinatorial (38,39)
labeling schemes, providing a route to NMR resonance
assignments of samples of limited solubility and stability.
Finally, the cell-free approach is uniquely suited for the in-
corporation of unnatural amino acids (31), in the present
work affording the facile incorporation of the unnatural
amino acid Bpa for photo-crosslinking. This method may
present a useful tool to probe structures of larger
replisomal complexes in the future.
CONCLUSION
The extraordinarily long flexible tether by which the
globular domain of the proofreading exonuclease is
attached to the polymerase subunit raises the expectation
of large conformational changes involved in the transition
from the polymerization to the proofreading mode.
Future studies may attempt to probe this by single-
molecule fluorescence resonance energy transfer (FRET)
experiments.
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